Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q61936565)
Watch
English
Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma
clinical trial
In more languages
edit
Statements
instance of
clinical trial
0 references
title
Phase II Trial of Cdk Inhibitor SCH 727965 in Multiple Myeloma
(English)
0 references
medical condition
multiple myeloma
0 references
sponsor
National Cancer Institute
0 references
country
Singapore
0 references
United States of America
0 references
start time
July 2009
0 references
end time
December 2011
0 references
number of participants
16
0 references
clinical trial phase
phase II clinical trial
0 references
research site
Mayo Clinic
0 references
National University Hospital
0 references
research subject recruitment status
completed
0 references
minimum age
18
year
0 references
study type
interventional study
0 references
Identifiers
ClinicalTrials.gov ID
NCT01096342
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit